Rapid measurement of plasma concentration of a molecular-targeted agent, pazopanib, with diamond sensor.
-
- Takuro Saiki
- Dept Mol Physiol, Niigata Univ Sch Med Dept Med Oncol, Niigata Univ Sch Med
-
- Ogata Genki
- Dept Mol Physiol, Niigata Univ Sch Med
-
- Kato Rito
- Dept Mol Physiol, Niigata Univ Sch Med
-
- Razvina Olga
- Dept Mol Physiol, Niigata Univ Sch Med
-
- Sawamura Seishiro
- Dept Mol Physiol, Niigata Univ Sch Med
-
- Matsumoto Yoshifumi
- Dept Med Oncol, Niigata Univ Sch Med
-
- Hanawa Ai
- Dept of Chem, Fac of Sci and Tech, Keio Univ
-
- Asai Kai
- Dept of Chem, Fac of Sci and Tech, Keio Univ
-
- Einaga Yasuaki
- Dept of Chem, Fac of Sci and Tech, Keio Univ
-
- Saijo Yasuo
- Dept Med Oncol, Niigata Univ Sch Med
-
- Hibino Hiroshi
- Dept Mol Physiol, Niigata Univ Sch Med
Bibliographic Information
- Other Title
-
- ダイヤモンドセンサを用いた血漿中分子標的薬濃度の迅速な測定法
Description
<p>Molecular-targeted anticancer drugs elicit less toxicity than conventional reagents. Yet, patients often suffer from severe adverse effects. A reason is 'fixed dosage' administration of the drug to all the patients regardless of their body size and complications; because of this strategy, the plasma concentration seems to exceed the therapeutic window occasionally. Although frequent measurement of the drug level at a clinical site is a solution, currently available methods such as mass spectrometry are time and cost consuming. To overcome these shortcomings, in this study, we developed a procedure with an electrochemical sensor composed of a conductive diamond, which yields more stable reactions than conventional materials. When guinea-pig plasma mixed with pazopanib, a multi-kinase inhibitor, was tested, the sensor detected a clinically relevant concentration of 3 to 300 µM. Time and sample amount necessary for each series of the measurement was <1 min and 100 µL, respectively. The sensor was repeatedly usable with minimal impairment of the sensitivity, saving the cost for the assay. This rapid and easily-handed method may enable therapeutic drug monitoring and accelerate tailored medicine for cancer.</p>
Journal
-
- Proceedings for Annual Meeting of The Japanese Pharmacological Society
-
Proceedings for Annual Meeting of The Japanese Pharmacological Society 93 (0), 1-YIA-18-, 2020
Japanese Pharmacological Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390565134836762240
-
- NII Article ID
- 130007811478
-
- ISSN
- 24354953
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed